{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:30Z","timestamp":1790931330136,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangzhou Science and Technology Projects","award":["2025A03J4222"],"award-info":[{"award-number":["2025A03J4222"]}]},{"name":"Guangzhou Key Research and Development Program","award":["2024C-GX16"],"award-info":[{"award-number":["2024C-GX16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08082-z","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:38:04Z","timestamp":1784511484000},"page":"7476-7488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson\u2019s disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Xiuhang","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenPeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiQiong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"8082_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:435\u201350. https:\/\/doi.org\/10.1038\/nrn.2017.62.","journal-title":"Nat Rev Neurosci"},{"key":"8082_CR2","doi-asserted-by":"publisher","unstructured":"B\u00e4ckstr\u00f6m D, Gran\u00e5sen G, Domell\u00f6f ME, Linder J, Jakobson Mo S, Riklund K et al. Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology. 2018; 91:e2045-e2056. https:\/\/doi.org\/10.1212\/wnl.0000000000006576","DOI":"10.1212\/wnl.0000000000006576"},{"key":"8082_CR3","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/mds.23823","volume":"26","author":"I Litvan","year":"2011","unstructured":"Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, et al. MDS Task Force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI. Mov Disord. 2011;26:1814\u201324. https:\/\/doi.org\/10.1002\/mds.23823.","journal-title":"Mov Disord"},{"key":"8082_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat reviews Disease primers. 2021;7:47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3.","journal-title":"Nat reviews Disease primers"},{"key":"8082_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mds.27617","volume":"34","author":"J Hoogland","year":"2019","unstructured":"Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, et al. Risk of Parkinson\u2019s disease dementia related to level I MDS PD-MCI. Mov. Disord. 2019;34:430\u20135. https:\/\/doi.org\/10.1002\/mds.27617.","journal-title":"Disord"},{"key":"8082_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41582-025-01163-x","volume":"22","author":"P Oikonomou","year":"2026","unstructured":"Oikonomou P, Akhoundi FH, Olfati N, Litvan I. Characteristics and mechanisms of cognitive impairment in Parkinson disease. Nat Rev Neurol. 2026;22:90\u2013109. https:\/\/doi.org\/10.1038\/s41582-025-01163-x.","journal-title":"Nat Rev Neurol"},{"key":"8082_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T. Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies. Ann Neurol. 2017;82:873\u201382. https:\/\/doi.org\/10.1002\/ana.25103.","journal-title":"Ann Neurol"},{"key":"8082_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","volume":"51","author":"SJ Chung","year":"2018","unstructured":"Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, et al. Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;51:43\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.048.","journal-title":"Parkinsonism Relat Disord"},{"key":"8082_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/jnnp-2018-320157","volume":"90","author":"J Pasquini","year":"2019","unstructured":"Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, et al. Clinical implications of early caudate dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2019;90:1098\u2013104. https:\/\/doi.org\/10.1136\/jnnp-2018-320157.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8082_CR10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1177\/13872877251386839","volume":"108","author":"JY Shao","year":"2025","unstructured":"Shao JY, Shen Y, Li R, Xiang XF, Li CH, Sun ZY, et al. Relationship between striatal dopaminergic depletion and cognitive milestone in Parkinson\u2019s disease: A comprehensive analysis of striatal subregions, laterality, and nonlinear relationships. J Alzheimers Dis. 2025;108:1388\u201397. https:\/\/doi.org\/10.1177\/13872877251386839.","journal-title":"J Alzheimers Dis"},{"key":"8082_CR11","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/mds.28192","volume":"35","author":"I Markaki","year":"2020","unstructured":"Markaki I, Bergstr\u00f6m S, Tsitsi P, Remnest\u00e5l J, M\u00e5nberg A, Hertz E, et al. Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson\u2019s Disease. Mov Disord. 2020;35:2101\u20136. https:\/\/doi.org\/10.1002\/mds.28192.","journal-title":"Mov Disord"},{"key":"8082_CR12","doi-asserted-by":"publisher","first-page":"e48783","DOI":"10.1371\/journal.pone.0048783","volume":"7","author":"S Jesse","year":"2012","unstructured":"Jesse S, Lehnert S, Jahn O, Parnetti L, Soininen H, Herukka SK, et al. Differential sialylation of serpin A1 in the early diagnosis of Parkinson\u2019s disease dementia. PLoS ONE. 2012;7:e48783. https:\/\/doi.org\/10.1371\/journal.pone.0048783.","journal-title":"PLoS ONE"},{"key":"8082_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41531-023-00476-2","volume":"9","author":"S Lerche","year":"2023","unstructured":"Lerche S, Zimmermann M, Roeben B, Wurster I, Fries FL, Deuschle C, et al. Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD. NPJ Parkinson\u2019s disease. 2023;9:38. https:\/\/doi.org\/10.1038\/s41531-023-00476-2.","journal-title":"NPJ Parkinson\u2019s disease"},{"key":"8082_CR14","doi-asserted-by":"publisher","unstructured":"Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C et al. The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort. Annals of clinical and translational neurology. 2018; 5:1460\u201377. https:\/\/doi.org\/10.1002\/acn3.644","DOI":"10.1002\/acn3.644"},{"key":"8082_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349\u201356. https:\/\/doi.org\/10.1002\/mds.24893.","journal-title":"Mov Disord"},{"key":"8082_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"8082_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.14336\/ad.2024.0553","volume":"16","author":"G Palermo","year":"2024","unstructured":"Palermo G, Giannoni S, Tommasini L, Bellini G, Frosini D, Aghakhanyan G, et al. Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson\u2019s Disease. Aging Dis. 2024;16:1754\u201368. https:\/\/doi.org\/10.14336\/ad.2024.0553.","journal-title":"Aging Dis"},{"key":"8082_CR18","doi-asserted-by":"publisher","first-page":"e210105","DOI":"10.1212\/wnl.0000000000210105","volume":"103","author":"HS Yoo","year":"2024","unstructured":"Yoo HS, Kim HK, Na HK, Kang S, Park M, Ahn SJ, et al. Association of Striatal Dopamine Depletion and Brain Metabolism Changes With Motor and Cognitive Deficits in Patients With Parkinson Disease. Neurology. 2024;103:e210105. https:\/\/doi.org\/10.1212\/wnl.0000000000210105.","journal-title":"Neurology"},{"key":"8082_CR19","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-025-07137-x","volume":"52","author":"S Seo","year":"2025","unstructured":"Seo S, Yoon YJ, Lee S, Lim H, Choo K, Kim D, et al. Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2025;52:2307\u201316. https:\/\/doi.org\/10.1007\/s00259-025-07137-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8082_CR20","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1212\/wnl.0000000000207725","volume":"101","author":"K Tsukita","year":"2023","unstructured":"Tsukita K, Sakamaki-Tsukita H, Kaiser S, Zhang L, Messa M, Serrano-Fernandez P, et al. High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression. Neurology. 2023;101:e1434\u201347. https:\/\/doi.org\/10.1212\/wnl.0000000000207725.","journal-title":"Neurology"},{"key":"8082_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","volume":"20","author":"T Liu","year":"2023","unstructured":"Liu T, Zuo H, Ma D, Song D, Zhao Y, Cheng O. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study. J Neuroinflammation. 2023;20:167. https:\/\/doi.org\/10.1186\/s12974-023-02843-5.","journal-title":"J Neuroinflammation"},{"key":"8082_CR22","doi-asserted-by":"publisher","first-page":"e16388","DOI":"10.1111\/ene.16388","volume":"31","author":"M Zimmermann","year":"2024","unstructured":"Zimmermann M, Fandrich M, Jakobi M, R\u00f6ben B, Wurster I, Lerche S, et al. Association of elevated cerebrospinal fluid levels of the longevity protein \u03b1-Klotho with a delayed onset of cognitive impairment in Parkinson\u2019s disease patients. Eur J Neurol. 2024;31:e16388. https:\/\/doi.org\/10.1111\/ene.16388.","journal-title":"Eur J Neurol"},{"key":"8082_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10072-022-06440-x","volume":"44","author":"F Nabizadeh","year":"2023","unstructured":"Nabizadeh F, Pirahesh K, Ramezannezhad E. Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson\u2019s disease. Neurol Sci. 2023;44:573\u201385. https:\/\/doi.org\/10.1007\/s10072-022-06440-x.","journal-title":"Neurol Sci"},{"key":"8082_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1877718x251396322","volume":"16","author":"J Hyun Lee","year":"2026","unstructured":"Hyun Lee J, Park M, Ahn SJ, Lee JH, Ryu YH, Yoo HS, et al. Association of dopamine depletion and cholinergic basal forebrain atrophy with brain metabolism and cognition in Parkinson\u2019s disease. J Parkinsons Dis. 2026;16:87\u201398. https:\/\/doi.org\/10.1177\/1877718x251396322.","journal-title":"J Parkinsons Dis"},{"key":"8082_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41531-025-01100-1","volume":"11","author":"H Cao","year":"2025","unstructured":"Cao H, Zhao Y, Chen Z, Zou X, Du X, Yi L, et al. Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts. NPJ Parkinson\u2019s disease. 2025;11:240. https:\/\/doi.org\/10.1038\/s41531-025-01100-1.","journal-title":"NPJ Parkinson\u2019s disease"},{"key":"8082_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00415-025-13359-8","volume":"272","author":"J Wang","year":"2025","unstructured":"Wang J, Sun X, Yin Y, Cao R. Longitudinal decline in striatal DAT binding in LRRK2 Parkinson\u2019s disease: connections with CSF \u03b1-synuclein seeding activity. J Neurol. 2025;272:630. https:\/\/doi.org\/10.1007\/s00415-025-13359-8.","journal-title":"J Neurol"},{"key":"8082_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/08919887251397641","volume":"39","author":"A McNamara","year":"2026","unstructured":"McNamara A, Ellul BP, Baetu I, Jenkinson M, Laurenz S, Collins-Praino L. Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Prognosis in Early Parkinson\u2019s Disease. J Geriatr Psychiatry Neurol. 2026;39:471\u201387. https:\/\/doi.org\/10.1177\/08919887251397641.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"8082_CR28","doi-asserted-by":"publisher","first-page":"fcac343","DOI":"10.1093\/braincomms\/fcac343","volume":"5","author":"L Winchester","year":"2023","unstructured":"Winchester L, Barber I, Lawton M, Ash J, Liu B, Evetts S, et al. Identification of a possible proteomic biomarker in Parkinson\u2019s disease: discovery and replication in blood, brain and cerebrospinal fluid. Brain Commun. 2023;5:fcac343. https:\/\/doi.org\/10.1093\/braincomms\/fcac343.","journal-title":"Brain Commun"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08082-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:31:46Z","timestamp":1790929906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8082"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08082-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The PPMI study was approved by the institutional review board or ethics committee at each participating site, and all participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no financial or non-financial competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}